Skip to main content
. 2020 Jun 8;114(9):666–673. doi: 10.1093/trstmh/traa038

Table 3.

Associations between catastrophic costs and unsuccessful TB treatment outcome

Variables Unsuccessful treatmenta, n/N (%) cOR (95% CI) p-Value aOR (95% CI)b p-Value
Catastrophic costs, threshold of 10%
 Yes 12/117 (10.3) 2.60 (0.87 to 7.80) 0.09 2.59 (0.78 to 8.63) 0.12
 No 6/135 (4.4) 1 1
Catastrophic costs, threshold of 15%
 Yes 10/97 (10.3) 2.21 (0.76 to 6.38) 0.14 2.31 (0.72 to 7.47) 0.16
 No 8/155 (5.2) 1 1
Catastrophic costs, threshold of 20%
 Yes 8/83 (9.6) 1.74 (0.61 to 4.97) 0.30 1.80 (0.55 to 5.88) 0.33
 No 10/169 (5.9) 1 1
Catastrophic costs, threshold of 25%
 Yes 8/66 (12.1) 2.65 (0.92 to 7.69) 0.07 3.03 (0.89 to 10.31) 0.08
 No 10/186 (5.4) 1 1
Catastrophic costs, threshold of 30%
 Yes 8/55 (14.5) 3.32 (1.13 to 9.69) 0.03 3.86 (1.11 to 13.38) 0.03
 No 10/197 (5.1) 1 1
Catastrophic costs, threshold of 35%
 Yes 2/44 (4.5) 0.53 (0.11 to 2.51) 0.42 0.53 (0.10 to 2.86) 0.46
 No 16/208 (7.7) 1 1
a

The number (%) of patients with unsuccessful treatment among those who experienced or did not experience catastrophic costs.

b

aORs of unsuccessful treatment comparing patients with and without catastrophic costs after adjustment for all potential confounders for which we had information (i.e. age, sex, district, education, previous TB treatment, initial sputum result, hospitalization and adverse drug effect).